| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/12/2011 | US20110112118 2,4-Diaminoquinazolines for Spinal Muscular Atrophy |
| 05/12/2011 | US20110112103 5-hydroxypyrimidine-4-carboxamide compound |
| 05/12/2011 | US20110112098 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules |
| 05/12/2011 | US20110112097 Substituted imidazoline-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 05/12/2011 | US20110112096 Pyrimidine derivatives as kinase inhibitors |
| 05/12/2011 | US20110112092 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 05/12/2011 | US20110112091 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a methof of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 05/12/2011 | US20110112088 Pyrazoles for the treatment of obesity and other cns disorders |
| 05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/12/2011 | US20110112083 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof |
| 05/12/2011 | US20110112081 Inhibitors of janus kinases |
| 05/12/2011 | US20110112080 Oxazoline derivatives |
| 05/12/2011 | US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/12/2011 | US20110112075 Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin |
| 05/12/2011 | US20110112074 Chlorothiophene-isoxazoles as inhibitors of coagulation factors xa and thrombin |
| 05/12/2011 | US20110112073 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 05/12/2011 | US20110112071 Novel heterocyclidene acetamide derivative |
| 05/12/2011 | US20110112070 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases |
| 05/12/2011 | US20110112067 Inhibitors of the Human Aldosterone Sythase CYP11B2 |
| 05/12/2011 | US20110112065 Modulators of dopamine neurotransmission |
| 05/12/2011 | US20110112063 Pyrimidine derivatives as kinase inhibitors |
| 05/12/2011 | US20110112061 Pyridazinones, the preparation and the use thereof |
| 05/12/2011 | US20110112060 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 05/12/2011 | US20110112051 Dipeptidyl Peptidase-IV Inhibitors |
| 05/12/2011 | US20110111162 Indolium compound and optical recording material containing the same |
| 05/12/2011 | US20110111046 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors |
| 05/12/2011 | CA2778115A1 Imidazole derivatives as ido inhibitors |
| 05/11/2011 | EP2319890A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter |
| 05/11/2011 | EP2319837A1 Benzimidazole derivatives and their use for modulating the GABAa receptor complex |
| 05/11/2011 | EP2319831A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 05/11/2011 | EP2318401A2 Azaindole inhibitors of iap |
| 05/11/2011 | EP2318400A1 1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists |
| 05/11/2011 | EP2318399A1 Piperidinyl gpcr agonists |
| 05/11/2011 | EP2318392A2 Pyrimidine derivatives as kinase inhibitors |
| 05/11/2011 | EP2318391A1 Tricyclic heterocycle derivatives as histamine h3 antagonists |
| 05/11/2011 | EP2318389A1 Pyridazine derivatives as smo inhibitors |
| 05/11/2011 | EP2318387A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |
| 05/11/2011 | EP2318380A2 Methods of Preparing Imidazole-Based Bicyclic Compounds |
| 05/11/2011 | EP2318376A1 Bi-1h-benzimidazoles as hepatitis c virus inhibitors |
| 05/11/2011 | EP2318370A1 Fluorinated heteroaryls |
| 05/11/2011 | EP2318369A1 Squaric acid derivatives as inhibitors of the nicotinamide |
| 05/11/2011 | EP1763517B1 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 05/11/2011 | EP1411929B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/11/2011 | CN102056923A New co-crystal compound of rivaroxaban and malonic acid |
| 05/11/2011 | CN102056922A Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIA |
| 05/11/2011 | CN102056921A Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 05/11/2011 | CN102056902A Imidazolidine derivatives |
| 05/11/2011 | CN102056894A Homocysteine synthase inhibitor |
| 05/11/2011 | CN102050820A Preparation method of compound with optical activity |
| 05/11/2011 | CN102050819A Oxazolidone derivative as well as preparation method and purposes thereof |
| 05/11/2011 | CN101585817B Method for the effective synthesis of optically active oxazoline-2-ketone derivative and uses |
| 05/11/2011 | CN101080405B Quaternary ammonium salts as M3 antagonists |
| 05/11/2011 | CN101007804B 1,3-benzodioxole-2,2-dicarboxylic acid derivatives and their preparation method and medicinal uses |
| 05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7939671 Compounds that inhibit (block) bitter taste in composition and use thereof |
| 05/10/2011 | US7939670 Nociceptin analogs |
| 05/10/2011 | US7939658 Enantiomeric pure beta agonists, manufacturing and use as a medicaments thereof |
| 05/10/2011 | US7939657 N-substituted benzene sulfonamides |
| 05/10/2011 | US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 05/10/2011 | US7939536 Pyrimidinylisoxazole derivatives |
| 05/10/2011 | US7939533 Dual NK1/NK3 receptor antagonists |
| 05/10/2011 | US7939528 Heterocycle compounds |
| 05/10/2011 | US7939527 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase |
| 05/10/2011 | US7939524 5,6-dihydro-1H-pyridin-2-one compounds |
| 05/10/2011 | CA2614746C Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 05/10/2011 | CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 05/10/2011 | CA2375605C Peptide leukotriene receptor |
| 05/05/2011 | WO2011053706A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
| 05/05/2011 | WO2011053705A1 Pyrimidine compounds as delta opioid receptor modulators |
| 05/05/2011 | WO2011053701A1 Phenoxy-substituted pyrimidines as opioid receptor modulators |
| 05/05/2011 | WO2011053508A1 ALKYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | WO2011052756A1 Novel 3-hydroxy-5-arylisoxazole derivative |
| 05/05/2011 | WO2011051961A1 Compounds for the treatment of dyslipidemia and related diseases |
| 05/05/2011 | WO2011051858A1 Imidazole derivatives as casein kinase inhibitors |
| 05/05/2011 | WO2011051540A1 Androgen receptor modulating compounds |
| 05/05/2011 | WO2011051393A1 Herbicidal tetrahydrophthalimides |
| 05/05/2011 | WO2011051201A1 Positive allosteric modulators (pam) |
| 05/05/2011 | WO2011051191A1 Non-crystallising bis-oxazolidines |
| 05/05/2011 | WO2010151737A3 Heterocyclic compounds and their uses as inhibitors of pi3 k activity |
| 05/05/2011 | WO2010110685A3 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| 05/05/2011 | US20110106241 Compositions and methods for inhibiting sphingosine kinase |
| 05/05/2011 | US20110105749 Triazole compounds that modulate hsp90 activity |
| 05/05/2011 | US20110105747 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 05/05/2011 | US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 05/05/2011 | US20110105567 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity |
| 05/05/2011 | US20110105530 Organic compounds |
| 05/05/2011 | US20110105526 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 05/05/2011 | US20110105524 Cysteine protease inhibitors |
| 05/05/2011 | US20110105523 Bifeprunox derivatives |
| 05/05/2011 | US20110105513 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105504 Inhibitors Of 11beta-Hydroxysteroid Dehydrogenase Type 1 |
| 05/05/2011 | US20110105503 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent |
| 05/05/2011 | US20110105502 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 05/05/2011 | US20110105500 Pyrazine substituted purines |
| 05/05/2011 | US20110105494 Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
| 05/05/2011 | US20110105493 HETEROCYCLYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105492 ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105486 Thiazole derivatives |
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | US20110105483 Triazole compounds that modulate hsp90 activity |